Versions - Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma: Schlussbericht : Laufzeit des Vorhabens:... by Seckinger, Anja (Author) , Ganzinger, Matthias (Author) , Hose, Dirk (Author) ,

    Ruprechts-Karls-Universität Heidelberg [2018?]

    Get full text
    Other
  2. 2

    Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma: Schlussbericht : Laufzeit des Vorhabens:... by Seckinger, Anja (Author) , Ganzinger, Matthias (Author) , Hose, Dirk (Author) ,

    Ruprechts-Karls-Universität Heidelberg [2018?]

    Get full text
    Other